Concepts (44)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibody-Dependent Cell Cytotoxicity | 5 | 2010 | 41 | 0.620 |
Why?
|
| Antigens, CD20 | 3 | 2009 | 33 | 0.600 |
Why?
|
| Fucose | 3 | 2006 | 14 | 0.540 |
Why?
|
| Oligosaccharides | 3 | 2006 | 25 | 0.540 |
Why?
|
| Antibodies, Monoclonal | 4 | 2010 | 1395 | 0.430 |
Why?
|
| Immunoglobulin G | 3 | 2008 | 464 | 0.340 |
Why?
|
| Lymphoma | 2 | 2010 | 247 | 0.340 |
Why?
|
| Glycoproteins | 3 | 2008 | 220 | 0.330 |
Why?
|
| Protein Engineering | 2 | 2009 | 150 | 0.320 |
Why?
|
| Antigens, Neoplasm | 3 | 2008 | 355 | 0.310 |
Why?
|
| Complement Activation | 1 | 2009 | 84 | 0.300 |
Why?
|
| CHO Cells | 5 | 2009 | 187 | 0.280 |
Why?
|
| Cricetinae | 5 | 2009 | 532 | 0.260 |
Why?
|
| Antibody Specificity | 1 | 2006 | 126 | 0.240 |
Why?
|
| Antibodies, Bispecific | 1 | 2006 | 38 | 0.240 |
Why?
|
| Cricetulus | 4 | 2009 | 122 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 2303 | 0.180 |
Why?
|
| Receptors, IgG | 3 | 2010 | 68 | 0.150 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 3 | 2010 | 78 | 0.110 |
Why?
|
| Rituximab | 3 | 2010 | 128 | 0.110 |
Why?
|
| Complement System Proteins | 1 | 2009 | 86 | 0.070 |
Why?
|
| Animals | 5 | 2009 | 28155 | 0.070 |
Why?
|
| Neutrophils | 1 | 2010 | 324 | 0.070 |
Why?
|
| CD52 Antigen | 1 | 2008 | 6 | 0.070 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2008 | 33 | 0.070 |
Why?
|
| Carbohydrates | 1 | 2008 | 46 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2010 | 2755 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 208 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 555 | 0.060 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2006 | 26 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 729 | 0.060 |
Why?
|
| Mucin-1 | 1 | 2006 | 46 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2008 | 476 | 0.060 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 2005 | 11 | 0.060 |
Why?
|
| Fucosyltransferases | 1 | 2005 | 9 | 0.060 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2006 | 86 | 0.060 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2005 | 87 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2006 | 422 | 0.060 |
Why?
|
| Apoptosis | 1 | 2010 | 1721 | 0.050 |
Why?
|
| Humans | 5 | 2010 | 93515 | 0.030 |
Why?
|
| Mutation | 1 | 2005 | 4272 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2010 | 89 | 0.020 |
Why?
|
| Asparagine | 1 | 2005 | 28 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 2005 | 107 | 0.010 |
Why?
|